Skip to main content
Aster DM Healthcare Limited logo

Aster DM Healthcare Limited — Investor Relations & Filings

Ticker · ASTERDM ISIN · INE914M01019 LEI · 335800TFWMBMRZEICW46 BSE.NS Human health and social work activities
Open in API
Filings indexed 897 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country IN India
Listing BSE.NS ASTERDM

About Aster DM Healthcare Limited

https://www.asterdmhealthcare.in/

Aster DM Healthcare Limited is an integrated healthcare service provider that operates a diversified network of hospitals, medical centers, and pharmacies. The organization provides a comprehensive spectrum of medical services spanning primary, secondary, tertiary, and quaternary care. Its operational framework utilizes a multi-brand strategy, including Aster, Medcare, and Access, to address various patient demographics and clinical requirements. The company’s infrastructure comprises multi-specialty facilities, diagnostic laboratories, and retail pharmacy outlets. Key offerings include specialized surgical procedures, complex clinical treatments, and outpatient consultations, all supported by advanced medical technology and a multi-disciplinary team of healthcare professionals.

Recent filings

Filing Released Lang Actions
Intimation of schedule of Analyst / Institutional Investors Meeting
Regulatory Filings Classification · 78% confidence The document is an intimation to stock exchanges under SEBI LODR Regulation 30 about the schedule of upcoming analyst/institutional investor meetings. It does not contain financial results, presentations, or detailed reports, nor does it announce dividends, director dealings, or corporate governance changes. It is a routine regulatory disclosure, so it falls into the catch-all “Regulatory Filings” category.
2026-05-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a short SEBI Listing Obligations disclosure notifying the schedule of Analyst/Institutional Investors meetings to the stock exchanges. It does not contain financial statements, earnings, or detailed presentations—rather it is a regulatory announcement under Listing Regulations. This falls under the generic Regulatory Filings (RNS) category.
2026-05-25 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 95% confidence The document is a declaration under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, stating that no new encumbrances have been made by the promoter and persons acting in concert during the financial year 2025-2026. It is a regulatory compliance statement related to shareholding and takeover regulations, not a financial report, meeting material, or other specific filings. The document is short (1344 characters) and serves as a formal notification to stock exchanges and the audit committee. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-05-19 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 95% confidence The document is a declaration under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, stating that no new encumbrances have been made during the financial year 2025-2026. It is addressed to stock exchanges and the audit committee, indicating a regulatory compliance filing related to shareholding disclosures. The content is a formal declaration rather than a report or announcement of financial results, management changes, or capital activities. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-05-19 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 86% confidence The document is a compliance declaration under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It does not present financial statements, earnings data, or meeting materials, nor does it announce a report publication. Instead, it is a regulatory compliance notice submitted to stock exchanges and audit committee. This fits the fallback category for miscellaneous regulatory filings (RNS).
2026-05-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is an exchange filing under SEBI LODR Regulation 30 notifying the schedule of an Analyst/Institutional Investor Meet. It does not contain financial results, presentation materials, or constitute a full report—it is a routine regulatory disclosure. There is no indication of an attached report or substantive financial data, nor is it an investor presentation itself. Therefore, it falls under the catch-all Regulatory Filings category.
2026-05-15 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.